Hepatitis

  • Most Topular Stories

  • Hepatocellular carcinoma: new advances in diagnosis, staging and treatment all predicted to improve patient outcomes

    Liver Disease / Hepatitis News From Medical News Today
    15 Apr 2014 | 1:00 am
    Epidemiological, genetic and clinical data presented at the International Liver CongressTM 2014 are collectively focussed on different approaches designed to improve the diagnosis, staging and...
  • Government Impact of Hep C Drug Price Tag

    Hepatitis Central
    Nicole Cutler L.Ac.
    2 Apr 2014 | 12:03 pm
    Gilead Sciences Inc. has developed Sovaldi, an FDA-approved, once-daily pill that has dramatically improved the odds of beating Hepatitis C. Although millions of people could likely benefit from Sovaldi, Gilead has priced this medication above and beyond what most would consider to be a reasonable fee. Gilead insists that Sovaldi’s cost is justified, but the stress it will put on America’s struggling healthcare system is yet to be realized. Millions of dollars and many years of research and development are spent by pharmaceutical companies to find the best cure for what ails us. When it…
  • Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009

    MedWorm: Hepatitis B
    31 Mar 2014 | 4:00 pm
    CONCLUSIONS: From both direct cost and societal perspectives, vaccinating children as recommended with these vaccines results in substantial cost savings. (Source: PEDIATRICS)MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.
  • What Are the Side Effects of Ribavirin Treatment?

    About.com Hepatitis: What's Hot Now
    hepatitis.guide@about.com
    16 Apr 2014 | 4:08 am
    Ribavirin has many side effects. Here are the most common side effects when treating hepatitis C with ribavirin and interferon.
  • HCV RNA

    About.com Hepatitis: Most Popular Articles
    16 Apr 2014 | 4:57 am
    Definition of HCV RNA. Hepatitis.
 
  • add this feed to my.Alltop

    About.com Hepatitis: What's Hot Now

  • What Are the Side Effects of Ribavirin Treatment?

    hepatitis.guide@about.com
    16 Apr 2014 | 4:08 am
    Ribavirin has many side effects. Here are the most common side effects when treating hepatitis C with ribavirin and interferon.
  • Six Common Questions About Spreading Hepatitis C

    hepatitis.guide@about.com
    16 Apr 2014 | 4:08 am
    How can you get hepatitis C? Here are answers to six common questions about how hepatitis C spreads and how you can and cannot get hepatitis C.
  • Chronic Hepatitis Nutrition

    hepatitis.guide@about.com
    16 Apr 2014 | 4:08 am
    What should someone with chronic hepatitis eat? This is a common concern for people with chronic hepatitis and the answer may surprise you. There is no single recommended diet for people with hepatitis, just basic nutritional principles. With these principles, you and your physician can develop a diet that gives your body the nutrition it needs without putting additional stress on your liver.
  • How Healthy is Your Liver?

    hepatitis.guide@about.com
    16 Apr 2014 | 4:08 am
    Liver enzymes allow doctors to learn about the health of your liver. There are thousands of these enzymes in the liver and blood stream, but two of them--two aminotransferases--are especially useful for determining liver disease: AST and ALT.
  • Can I Donate Blood if I Have Hepatitis?

    hepatitis.guide@about.com
    16 Apr 2014 | 4:08 am
    If you had any kind of viral hepatitis, or unexplained jaundice, at any time since you were age 11, you're not able to donate blood.
  • add this feed to my.Alltop

    About.com Hepatitis: Most Popular Articles

  • HCV RNA

    16 Apr 2014 | 4:57 am
    Definition of HCV RNA. Hepatitis.
  • Is It Dangerous to Visit Someone with Hepatitis...

    16 Apr 2014 | 4:57 am
    Is it safe to visit someone with hepatitis C? Basically, this includes most types of casual contact like talking, hugging, kissing, holding hands, and shaking hands.
  • Finding a Support Group

    16 Apr 2014 | 4:57 am
    Support groups can be excellent sources of information and encouragement. If have chronic hepatitis, finding and participating in a support group should be one of your first priorities. Here are five places you should check out if you're looking for a group to join.
  • Virus

    16 Apr 2014 | 4:57 am
    Definition of virus. Hepatitis.
  • Hepatitis C: Family, Career and Successful...

    16 Apr 2014 | 4:57 am
    Have you ever wondered how a medical professional would deal with a diagnosis of hepatitis C and the treatment process? In reality, the men and women who treat us often must struggle through the same ailments and they do it the same way as everyone else. In this interview, a hospital nurse describes how he lives his life with a career, family and hepatitis C. Page 2.
 
  • add this feed to my.Alltop

    Hepatitis Central

  • New Hepatitis C Study Cures 90% of Patients

    The Editors at Hepatitis Central
    11 Apr 2014 | 7:25 am
    Bristol-Myers hepatitis C treatment cures up to 90 percent in new study Published April 10, 2014 Reuters A combination of two anti-viral drugs developed by Bristol-Myers Squibb Co cured 90 percent of previously untreated hepatitis C patients and 82 percent of those who failed to respond to prior therapy, according to results from a late stage study presented on Thursday. The Phase III trial of more than 700 patients called Hallmark-Dual tested a combination of Bristol’s daclatasvir and asunaprevir over 24 weeks of therapy in patients with genotype 1b of the virus that causes progressive…
  • FREE Educational Webinar: What You Need to Know About HCV

    The Editors at Hepatitis Central
    7 Apr 2014 | 8:48 am
    A Discussion on HEPATITIS C: What You Need to Know When: Wednesday, April 23rd at 7pm. How to Register: http://meetthehcvexpert.com/Dieterich/registration.cfm?CFID=5439845&CFTOKEN=99387613
  • FREE WEBINAR Diagnosing and Treating HE: A Physician’s Perspective

    The Editors at Hepatitis Central
    7 Apr 2014 | 8:39 am
    The American Liver Foundation invites you to participateinthe second of a four-part series of live webinars on hepatic encephalopathy (HE) to be held Wednesday, April 23, 2014. The program, Diagnosing and Treating HE: A Physician’s Perspective, isdesigned for patients and caregivers who need a better grasp of this complicated condition or want a clearer understanding about a specific HE-related issue. HE is most often seen in people with chronic liver disease. It’s a major complication of cirrhosis – whether caused by viral hepatitis, fatty liver disease or long-term alcohol use. …
  • Gilead Gets Approved for Accelerated Assessment of Hep C Drug

    The Editors at Hepatitis Central
    3 Apr 2014 | 8:16 am
    Gilead Sciences receives EU green light for hepatitis C drug assessment April 1, 2014 in Pharmaceutical Company Product News Gilead Sciences has announced that the European Medicines Agency (EMA) has ratified its application for the assessment of a new treatment of chronic hepatitis C virus (HCV) infections. The regulator has accepted the company’s marketing authorisation application for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analogue polymerase inhibitor sofosbuvir (SOF) 400 mg, for the treatment of chronic HCV genotype 1.
  • Government Impact of Hep C Drug Price Tag

    Nicole Cutler L.Ac.
    2 Apr 2014 | 12:03 pm
    Gilead Sciences Inc. has developed Sovaldi, an FDA-approved, once-daily pill that has dramatically improved the odds of beating Hepatitis C. Although millions of people could likely benefit from Sovaldi, Gilead has priced this medication above and beyond what most would consider to be a reasonable fee. Gilead insists that Sovaldi’s cost is justified, but the stress it will put on America’s struggling healthcare system is yet to be realized. Millions of dollars and many years of research and development are spent by pharmaceutical companies to find the best cure for what ails us. When it…
  • add this feed to my.Alltop

    Hepatitis News

  • NHS England to fund hepatitis C drug Sovaldi

    16 Apr 2014 | 5:43 pm
    Hepatitis C patients in the UK … systems. The UK's Hepatitis C Trust had earlier expressed … ”.   Graham Foster, co-chair of the Hepatitis C Clinical Reference Group sub-group …
  • Drug boost for severe hepatitis C sufferers

    16 Apr 2014 | 4:36 pm
    … 500 patients with such severe hepatitis C that they are likely … with the advanced effects of hepatitis C except liver transplant.  The … not, more crucially, a cure. Hepatitis C primarily affects the liver … completed until May. But the Hepatitis C Trust and some clinicians …
  • Hepatitis C Drugs Not Reaching the Poor

    16 Apr 2014 | 2:55 pm
    … the first treatment guidelines for hepatitis C virus (HCV), and the … Wiktor, head of the global hepatitis program at the World Health …
  • State Officials Urge Caution After Hepatitis A Cases

    16 Apr 2014 | 2:25 pm
    … respond after a case of Hepatitis A in a food handler … can prevent the spread of Hepatitis A and other food-borne diseases …
  • New Us Research Chemicals & Medical Care Company Launches Custom Online Ordering

    16 Apr 2014 | 12:57 pm
    Us Research Chemicals & Medical Care is introducing an easy 3 step process to purchasing custom Research Chemicals in bulk or private label packaging options. ASHEVILLE, NC, UNITED STATES, April 17, 2014 /EINPresswire.com/ -- In these economic times …
 
  • add this feed to my.Alltop

    Hepatitis C Treatment News

  • Hep C class action hinges on one victim accepting deal

    16 Apr 2014 | 7:17 pm
    … have to go to trial. A trial would be time-consuming … Peters failed to disclose his hepatitis C status. The Health Department, … children and others. Many have developed crippling depression, anxiety and … Valium among other addictive drugs. The tribunal heard Dr …
  • Sofosbuvir/Ledipasvir Produces Early Cure for 100% of People with HIV and HCV Coinfection

    16 Apr 2014 | 4:52 pm
    … the genotype 1 hepatitis C virus (HCV). In their trial, Anu Osinusi of … of treatment and had continued virological response at the end of treatment. Results show that the combination treatment led to …
  • Hepatitis C Drugs Not Reaching the Poor

    16 Apr 2014 | 2:55 pm
    … first treatment guidelines for hepatitis C virus (HCV), and the advent of drugs that … December at $1,000 a pill — $84,000 for a 12-week … be able to produce the pills at $100–250 for a … that access to drugs will depend on the development of cheap diagnostics …
  • Patients Paying Much More for Specialty Drugs

    16 Apr 2014 | 2:41 pm
    … makers have increasingly focused on developing drugs for less common and more … 2013, 36 new drugs were introduced, including treatments for cancer, hepatitis C, diabetes, and multiple sclerosis. Those new drugs also …
  • J&J's Olysio makes strong debut in Q1 as firm raises 2014 guidance

    16 Apr 2014 | 2:17 pm
    … of care for all-oral hepatitis C virus treatment in the United … drugs, were behind the strong growth in the quarter. Notably, hepatitis C … USD1,000 per pill granted US FDA approval). US … pharmaceutical expenditure on HCV medication is anticipated to soar …
 
  • add this feed to my.Alltop

    Hepatitis Blog

  • Hepatitis A Week: Charlotte, North Carolina Papa John’s and Nyack, New York La Fontana

    Bill Marler
    12 Apr 2014 | 8:49 am
    Charlotte North Carolina: A Papa John’s outlet is to blame for a Hepatitis A scare, according to the Mecklenburg County Health Department. Anyone who ate food from the location on March 28 and 29 should get the Hepatitis A vaccine immediately. Officials are looking into a potential Hepatitis A outbreak from the Papa John’s location in the 8000 block of Cambridge Commons in Charlotte, near Harrisburg Road and I-485. According to the health department, a manager at that restaurant, who recently traveled out of the country, contracted Hepatitis A and may have infected Papa John’s patrons.
  • 28 with Hepatitis A in Norway

    Bill Marler
    30 Mar 2014 | 3:58 pm
    A total of 28 cases of hepatitis A infection have been reported over the last few months in Norway, where this disease is said to be rare, local health officials said. Health authorities, who were worried by the growing number of hepatitis A cases, are working to determine whether the sick people are infected from a common source. In almost half of the cases, the patients were found to have infected with hepatitis A virus while traveling abroad, The remaining half got infected in Norway, which was described as a rare occurrence. Infection of hepatitis A virus can also occur through person to…
  • New Zealand Apples and Peaches Recalled Over Hepatitis A Exposure

    Bill Marler
    16 Mar 2014 | 8:57 pm
    The Ministry for Primary Industries (MPI) is cautioning New Zealand consumers of a small quantity of fresh fruit sold in late February and early March that there is a relatively low risk that this fruit had been contaminated with Hepatitis A virus. MPI Deputy Director General Scott Gallacher says it is important that consumers understand the risk of transmission of the virus is relatively low, but MPI is issuing this information as a precaution so that people with any related concerns about their health can contact their doctor. “As always, MPI is placing the health and wellbeing of all…
  • Hepatitis A Vaccines Reccomended After Hilton Head Exposure

    Bill Marler
    26 Feb 2014 | 4:24 am
    The Hilton Head Island Packet reports that nearly 300 people might have been exposed to hepatitis A at Hudson’s Seafood House on the Docks restaurant February 15th, but so far no cases stemming from the exposure have been confirmed.  An employee at Hudson’s Seafood House on the Docks tested positive for hepatitis A on last Friday, six days after the employee had worked at the restaurant. Anyone who was at the restaurant from 4 p.m. until closing time February 15th — when the infected employee was working — should contact his or her primary care provider to receive a…
  • Hudson’s Seafood House Employee with Hepatitis A

    Bill Marler
    23 Feb 2014 | 2:18 am
    According to the South Carolina Department of Health and Environmental Control (DHEC), customers and staff of Hudson’s Seafood House on the Docks in Hilton Head Island who were present at the restaurant on the evening of February 15, 2014, are encouraged to contact their primary care provider to receive treatment for possible exposure to the Hepatitis A virus.  On Friday, DHEC was notified that an employee who worked at the restaurant on the evening of February 15 has tested positive for Hepatitis A. The employee is being treated for the infection and has not returned to work. Exposure…
  • add this feed to my.Alltop

    HCV New Drug Research

  • NHS England agrees funding for life-saving hepatitis C drug

    16 Apr 2014 | 10:47 am
    "The recommendation of NHS England’s Clinical Priorities Advisory Group (CPAG) means that whilst not yet NICE-approved, Sofosbuvir will be funded for those patients at significant risk of mortality or who require transplantation." NHS England agrees funding for life-saving hepatitis C drug16 April 2014 - 17:37NHS England has approved an £18.7 million investment in a new drug for the treatment of hepatitis C.Around 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Sofosbuvir.The hepatitis C virus causes…
  • Nick Harvey: There’s now a cure for hepatitis C… but the poor can’t afford it

    16 Apr 2014 | 5:45 am
    Nick Harvey: There’s now a cure for hepatitis C… but the poor can’t afford it15 Apr, 14 | by BMJPicture the scenario: a disease is destroying your liver and there’s a chance you will die. There’s a cure, but you can’t have it as it costs more than you earn. There are tens of millions more of people like you. Hundreds of thousands of them die every year. It sounds like some sci-fi dystopia, but this is the situation that the 150 million people who have hepatitis C virus (HCV) find themselves in today. HCV is spread through blood-to-blood contact, mostly through shared needles.
  • ViewPoints: Competitor dynamics shift in hepatitis C market

    16 Apr 2014 | 5:42 am
    ViewPoints: Competitor dynamics shift in hepatitis C market (Ref: ViewPoints Desk) FirstWord PharmaApril 15th, 2014 By: Simon King Continued rapid uptake of Gilead Sciences' hepatitis C treatment Sovaldi and questions surrounding the sustainability of pricing models in conjunction with demand for new therapies, provided the backdrop for this year's annual meeting of the European Association for the Study of the Liver (EASL) in London.Clinical data presented at the conference showcased both the next generation of hepatitis C therapies – designed to further improve convenience and raise…
  • Doctors, medical staff on drugs put patients at risk

    16 Apr 2014 | 5:24 am
    Doctors, medical staff on drugs put patients at riskBy Peter Eisler  A single addicted health care worker who resorts to “drug diversion,” the official term for stealing drugs, can endanger thousands. Nearly 8,000 people in eight states needed hepatitis tests after David Kwiatkowski, an itinerant hospital technician, was caught injecting himself with patients’ pain medicine and refilling the syringes with saline. He infected at least 46, mostly in New Hampshire. It was the third hepatitis outbreak since 2009 linked to a health care worker using patients’ syringes (the others were…
  • Updated Hepatitis C Trials- U.S. Recruiting: AbbVie ABT-493/ABT-530 Adults Genotype 1

    15 Apr 2014 | 2:18 pm
    The hepatitis C clinical trials on this page are not a complete list; to learn more about HCV trials or to find out if a study is enrolling patients in your area, please click  here. View additional hepatitis trials updated in the last 30 days @ ClinicalTrials.govTake the time to learn more about HCV agents currently in clinical trials by reviewing new research presented this month at the International Liver Congress 2014. Link to editorials, expert analysis, and slide presentations evaluating efficacy and safety of hepatitis C investigational interferon-free combinations with and…
 
Log in